Ginkgo Bioworks is a platform for cell programming, offering comprehensive, end-to-end services that address complex challenges across various industries, including food and agriculture, pharmaceuticals, and industrial chemicals. The company specializes in enzyme engineering, providing tailored solutions such as biocatalysts that replace traditional chemical synthesis steps, enhance enzyme functionality, and reduce manufacturing costs at scale. These innovations empower clients to optimize their R&D projects and improve overall efficiency.
At the heart of Ginkgo’s enzyme R&D is the use of artificial intelligence (AI), which opens new possibilities for enzyme design and application. Ginkgo integrates AI tools at every stage of development, from the discovery of novel enzymes to structure-guided engineering, manufacturing, and process optimization. The company’s AI-driven platform, Owl, combines computational tools refined through numerous projects with the expertise of Ginkgo’s enzyme engineering team. This combination enables Ginkgo to provide precise, data-driven solutions that meet the specific needs of each client.
Key features of Ginkgo’s platform include advanced enzyme discovery, computational design, and the Owl enzyme intelligence system, which uses generative AI and model fine-tuning to accelerate innovation. By harnessing AI, Ginkgo delivers cutting-edge enzyme-powered solutions that drive progress across various industries.
